InterviewUS bioplastics firm Cereplast to move ops to Indiana

04 January 2010 22:27  [Source: ICIS news]

NEW YORK (ICIS news)--US bioplastics company Cereplast is moving all of its operations from California to Indiana to save on costs, chairman and CEO Frederic Scheer said on Monday.

Cereplast plans to complete the move of its manufacturing and research and development operations from Hawthorne, California, to its new facility in Seymour, Indiana, by the end of first quarter this year, Scheer said in an interview with ICIS.

The company’s California facility has nameplate production capacity of 45m lb/year, which will be shut down. In its place, Cereplast will open a 50m lb/year facility in Indiana.

Cereplast said it is also on the verge of closing a partnership deal with a large US-based third-party compounder, which will also be announced in the first quarter. The compounder will produce most of Cereplast’s proprietary resins, said Scheer.

The moves are part of Cereplast’s restructuring program announced in May 2009, which will refocus the company on proprietary product development and marketing.

“We expect the restructuring program that we announced last year to be completed by the end of first quarter,” said Scheer.

“By that time, we also expect operations from our Indiana facility to have already been started. These represent the bulk of everything we’ve been doing since our restructuring announcement,” he added.

Cereplast expects its 2009 sales to come in at around $3m-$4m (€2.1m-€2.8m), compared with $4.5m in 2008. The company reported a decline in volume sales last year, which it attributed to the general economic downturn.

“Existing customers have delayed orders and/or launches of their own commercial applications of their resins due to the recession and global drop in plastic demand in general. When the economy is shrinking, the environment is usually not the top priority anymore,” said Scheer.

Scheer said he expects higher revenues for 2010 with the anticipation of lower operating costs resulting from the restructuring as well as the commercialisation of products incorporating its bio-resins from US-based customers such as paper company Georgia Pacific and juvenile products company Dorel Industries.

“We expect to see in the second quarter commercialisation of some of our customers’ products using our resin. The largest contract we finalized last year was with Georgia-Pacific, and we hope to see their products hit the shelves sometime in the first quarter of this year,” added Scheer.

Last December, Cereplast raised $2.23m from accredited and institutional investors by selling 44.6m shares of the company’s common stock at a price of $0.05/share.

($1 = €0.70)

To discuss issues facing the chemical industry go to ICIS connect
Bookmark Paul Hodges’ Chemicals and the Economy blog


By: Doris de Guzman
+1 713 525 2653



AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly

ICIS news FREE TRIAL
Get access to breaking chemical news as it happens.
ICIS Global Petrochemical Index (IPEX)
ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index